Evaluation and optimization of a commercial enzyme linked immunosorbent assay for detection of Chlamydophila pneumoniae IgA antibodies

BMC Infectious Diseases

Volumn 8, Issue , 2008, Pages

  Frikha Gargouri, Olfa ^a   Gdoura, Radhouane ^a   Znazen, Abir ^a   Ben Arab, Nozha ^b   Gargouri, Jalel ^c   Ben Jemaa, Mounir ^b   Hammami, Adnene ^a  

^a HABIB BOURGUIBA HOSPITAL   (Tunisia)

^b HEDI CHAKER HOSPITAL   (Tunisia)

^c Department of Blood Bank ^*  (Tunisia)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; BACTERIUM ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G;

ADULT; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; BACTERIAL PNEUMONIA; BLOOD ANALYSIS; BLOOD DONOR; BLOOD SAMPLING; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOFLUORESCENCE TEST; MAJOR CLINICAL STUDY; MALE; PREDICTION; PROCESS OPTIMIZATION; REFERENCE VALUE; REPRODUCIBILITY; ROC CURVE; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; STANDARDIZATION; BACTERIAL INFECTION; BLOOD; CASE CONTROL STUDY; EPIDEMIOLOGY; EVALUATION; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOLOGY; MIDDLE AGED; TUNISIA;

ADULT; ANTIBODIES, BACTERIAL; CASE-CONTROL STUDIES; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SEROEPIDEMIOLOGIC STUDIES; TUNISIA;

EID: 49749143670     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-8-98     Document Type: Article

References (47)

1. Grayston JT Kuo CC Wang SP Altman J A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections N Engl J Med 1986, 315:161-168 3724806
2. Hahn DL Chlamydia pneumoniae antibodies and adult-onset asthma J Allergy Clin Immunol 2000, 106:404 10.1067/mai.2000.108500 10932089
3. Dowell SF Peeling RW Boman J Carlone GM Fields BS Guarner J Hammerschlag MR Jackson LA Kuo CC Maass M Messmer TO Talkington DF Tondella ML Zaki SR C. pneumoniae Workshop Participants Standardizing Chlamydia pneumoniae assays: Recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada) Clin Infect Dis 2001, 33:492-503 10.1086/322632 11462186
4. Tomasi TB Grey HM Structure and function of immunoglobulin A Prog Allergy 1972, 16:81-213 4566143
5. Saikku P Epidemiology of Chlamydia pneumoniae in atherosclerosis Am Heart J 1999, 138:S500-S503 10.1016/S0002-8703(99)70285-1 10539858
6. Hahn DL Anttila T Saikku P Association of Chlamydia pneumoniae IgA antibodies with recently symptomatic asthma Epidemiol Infect 1996, 117:513-517 8972677
7. Saikku P Leinonen M Tenkanen L Linnanmäki E Ekman MR Manninen V Mänttäri M Frick MH Huttunen JK Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study Ann Intern Med 1992, 116:273-278 1733381
8. Strachan DP Carrington D Mendall MA Ballam L Morris J Butland BK Sweetnam PM Elwood PC Relation of Chlamydia pneumoniae serology to mortality and incidence of ischaemic heart disease over 13 years in the caerphilly prospective heart disease study BMJ 1999, 318:1035-1039 27832 10205100
9. Toss H Gnarpe J Gnarpe H Siegbahn A Lindahl B Wallentin L Increased fibrinogen levels are associated with persistent Chlamydia pneumoniae infection in unstable coronary artery disease Eur Heart J 1998, 19:570-577 10.1053/euhj.1997.0771 9597405
10. von Hertzen L Isoaho R Leinonen M Koskinen R Laippala P Töyrylä M Kivelä SL Saikku P Chlamydia pneumoniae antibodies in chronic obstructive pulmonary disease Int J Epidemiol 1996, 25:658-664 10.1093/ije/25.3.658 8671570
11. von Hertzen LC Chlamydia pneumoniae and its role in chronic obstructive pulmonary disease Ann Med 1998, 30:27-37 10.3109/07853899808999382 9556087
12. Campbell LA Kuo CC Grayston JT Chlamydia pneumoniae and cardiovascular disease Emerg Infect Dis 1998, 4:571-579 9866733
13. Saikku P Leinonen M Mattila K Ekman MR Nieminen MS Mäkelä PH Huttunen JK Valtonen V Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction Lancet 1988, 2:983-986 10.1016/ S0140-6736(88)90741-6 2902492
14. Falck G Engstrand I Gad A Gnarpe J Gnarpe H Laurila A Demonstration of Chlamydia pneumoniae in patients with chronic pharyngitis Scand J Infect Dis 1997, 29:585-589 10.3109/00365549709035899 9571739
15. Falck G Gnarpe J Hansson LO Svardsudd K Gnarpe H Comparison of individuals with and without specific IgA antibodies to Chlamydia pneumoniae: Respiratory morbidity and the metabolic syndrome Chest 2002, 122:1587-1593 10.1378/chest.122.5.1587 12426257
16. Peeling RW Wang SP Grayston JT Blasi F Boman J Clad A Freidank H Gaydos CA Gnarpe J Hagiwara T Jones RB Orfila J Persson K Puolakkainen M Saikku P Schachter J Chlamydia pneumoniae serology: Interlaboratory variation in microimmunofluorescence assay results J Infect Dis 2000, 181(Suppl 3):S426-S429 10.1086/315603 10839729
17. Wang SP Grayston JT Human serology in Chlamydia trachomatis infection with microimmunofluorescence J Infect Dis 1974, 130:388-397 4613759
18. Landis JR Koch GG An application of hierarchical kappa-type statistics in the assessment of majority agreement among multiple observers Biometrics 1977, 33:363-374 10.2307/2529786 884196
19. Greiner M Sohr D Gobel P A modified ROC analysis for the selection of cut-off values and the definition of intermediate results of serodiagnostic tests J Immunol Methods 1995, 185:123-132 10.1016/ 0022-1759(95)00121-P 7665894
20. Aldous MB Grayston JT Wang SP Foy HM Seroepidemiology of Chlamydia pneumoniae TWAR infection in Seattle families, 1966-1979 J Infect Dis 1992, 166:646-649 1500751
21. Gencay M Dereli D Ertem E Serter D Puolakkainen M Saikku P Boydak B Dereli S Ozbakkaloglu B Yorgancioglu A Tez E Prevalence of Chlamydia pneumoniae specific antibodies in different clinical situations and healthy subjects in Izmir, Turkey Eur J Epidemiol 1998, 14:505-509 10.1023/A:1007404315879 9744685
22. Kuo CC Jackson LA Campbell LA Grayston JT Chlamydia pneumoniae (TWAR) Clin Microbiol Rev 1995, 8:451-461 172870 8665464
23. Leinonen M Pathogenetic mechanisms and epidemiology of Chlamydia pneumoniae Eur Heart J 1993, 14(Suppl K):57-61 8131790
24. Saikku P The epidemiology and significance of Chlamydia pneumoniae J Infect 1992, 25(Suppl 1):27-34 10.1016/0163-4453(92)91913-V 1522335
25. Hermann C Graf K Groh A Straube E Hartung T Comparison of eleven commercial tests for Chlamydia pneumoniae-specific immunoglobulin G in asymptomatic healthy individuals J Clin Microbiol 2002, 40:1603-1609 130946 11980928 10.1128/JCM.40.5.1603-1609.2002
26. Romano Carratelli C Nuzzo I Cozzolino D Bentivoglio C Paolillo R Rizzo A Relationship between Chlamydia pneumoniae infection, inflammatory markers, and coronary heart diseases Int Immunopharmacol 2006, 6:848-853 10.1016/j.intimp.2005.10.012 16546716
27. Vammen S Lindholt JS Andersen PL Henneberg EW Ostergaard L Antibodies against Chlamydia pneumoniae predict the need for elective surgical intervention on small abdominal aortic aneurysms Eur J Vasc Endovasc Surg 2001, 22:165-168 10.1053/ejvs.2001.1414 11472052
28. Persson K Boman J Comparison of five serologic tests for diagnosis of acute infections by Chlamydia pneumoniae Clin Diagn Lab Immunol 2000, 7:739-744 95948 10973447 10.1128/CDLI.7.5.739-744.2000
29. Frikha-Gargouri O Znazen A Gdoura R Gargouri B Arab NB Jemaa MB Hammami A Usefulness of enzyme linked immunosorbent assays species specific in the detection of Chlamydia trachomatis and Chlamydophila pneumoniae IgG antibodies in patients with genital infections or respiratory tract infections Pathol Biol 2008, 56:143-147 10.1016/j.patbio.2007.09.020 18178034
30. Halvorsen DS Borvik T Njolstad I Gutteberg TJ Vorland LH Hansen JB Chlamydia pneumoniae IgA- and IgG antibodies in young survivors of myocardial infarction. A comparison of antibody detection by a microimmunofluorescence test and an enzyme immunoassay J Intern Med 2002, 251:142-147 10.1046/j.1365-2796.2002.00942.x 11905590
31. Ciervo A Petrucca A Visca P Cassone A Evaluation and optimization of ELISA for detection of anti-Chlamydophila pneumoniae IgG and IgA in patients with coronary heart diseases J Microbiol Methods 2004, 59:135-140 10.1016/j.mimet.2004.05.011 15325761
32. Ngeh J Gupta S Goodbourn C The reproducibility of an enzyme-linked immunosorbent assay for detection of Chlamydia pneumoniae-specific antibodies Clin Microbiol Infect 2004, 10:171-174 10.1111/ j.1469-0691.2004.00757.x 14759243
33. Paldanius M Bloigu A Alho M Leinonen M Saikku P Prevalence and persistence of Chlamydia pneumoniae antibodies in healthy laboratory personnel in Finland Clin Diagn Lab Immunol 2005, 12:654-659 1112086 15879028 10.1128/CDLI.12.5.654-659.2005
34. Hoymans VY Bosmans JM Van Renterghem L Mak R Ursi D Wuyts F Vrints CJ Ieven M Importance of methodology in determination of Chlamydia pneumoniae seropositivity in healthy subjects and in patients with coronary atherosclerosis J Clin Microbiol 2003, 41:4049-4053 193860 12958224 10.1128/JCM.41.9.4049-4053.2003
35. Jantos CA Heck S Roggendorf R Sen-Gupta M Hegemann JH Antigenic and molecular analyses of different Chlamydia pneumoniae strains J Clin Microbiol 1997, 35:620-623 229638 9041400
36. Black CM Johnson JE Farshy CE Brown TM Berdal BP Antigenic variation among strains of Chlamydia pneumoniae J Clin Microbiol 1991, 29:1312-1316 270107 1885727
37. Bennedsen M Berthelsen L Lind I Infection, Atherosclerosis and Macrolide Antibiotics Group Performance of three microimmunofluorescence assays for detection of Chlamydia pneumoniae immunoglobulin M, G, and A antibodies Clin Diagn Lab Immunol 2002, 9:833-839 120032 12093682 10.1128/CDLI.9.4.833-839.2002
38. Gnarpe J Sparr A Nääs J Lundbäck A Serological analysis of specific IgA to Chlamydia pneumoniae: Increased sensitivity of IgA antibody detection using prolonged incubation and high antigen concentration APMIS 2000, 108:357-362 10.1034/j.1600-0463.2000.d01-68.x 10937773
39. Vainas T De Graaf R Stassen FR Kurvers HA Grauls GE Kitslaar PJ Bruggeman CA Chlamydia pneumoniae serology: Comparing a commercial enzyme immunoassay and microimmunofluorescence test in patients with cardiovascular disease APMIS 2003, 111:363-369 10.1034/ j.1600-0463.2003.1110210.x 12716394
40. Paldanius M Bloigu A Leinonen M Saikku P Measurement of Chlamydia pneumoniae-specific immunoglobulin A (IgA) antibodies by the microimmunofluorescence (MIF) method: Comparison of seven fluorescein-labeled anti-human IgA conjugates in an in-house MIF test using one commercial MIF and one enzyme immunoassay kit Clin Diagn Lab Immunol 2003, 10:8-12 145278 12522032 10.1128/CDLI.10.1.8-12.2003
41. Wang S The microimmunofluorescence test for Chlamydia pneumoniae infection: Technique and interpretation J Infect Dis 2000, 181(Suppl 3):S421-S425 10.1086/315622 10839728
42. Yetkin G Chlamydia pneumoniae and coronary artery disease: Controversial results of serological studies Int Immunopharmacol 2006, 6:1524-1525 10.1016/j.intimp.2006.04.012 16846847
43. Wong YK Sueur JM Fall CH Orfila J Ward ME The species specificity of the microimmunofluorescence antibody test and comparisons with a time resolved fluoroscopic immunoassay for measuring IgG antibodies against Chlamydia pneumoniae J Clin Pathol 1999, 52:99-102 501051 10396235
44. Mitov I Haralambieva I Petrov D Ivanova R Kamarinchev B Iankov I Cross-reactive monoclonal antibodies raised against the lipopolysaccharide antigen of Salmonella minnesota Re chemotype: diagnostic relevance Diagn Microbiol Infect Dis 2003, 45:225-231 10.1016/ S0732-8893(02)00545-X 12729990
45. Maurin M Eb F Etienne J Raoult D Serological cross-reactions between Bartonella and Chlamydia species: Implications for diagnosis J Clin Microbiol 1997, 35:2283-2287 229955 9276403
46. Jackson LA Cherry JD Wang SP Grayston JT Frequency of serological evidence of Bordetella infections and mixed infections with other respiratory pathogens in university students with cough illnesses Clin Infect Dis 2000, 31:3-6 10.1086/313911 10913388
47. Nishimura M Hashimoto T Kobayashi H Fukuda T Okino K Yamamoto N Mashida C Kawagoe K Fujita H Inoue N Takahashi H Ono T Close association of Chlamydia pneumoniae IgA seropositivity by ELISA with the presence of coronary artery stenosis in haemodialysis patients Nephrol Dial Transplant 2005, 20:1944-1950 10.1093/ndt/gfh906 15956072